Wednesday, July 8, 2026

Drug profile · INN

primaquine phosphate

primaquine phosphate (PRIMAQUINE PHOSPHATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — primaquine phosphate
US status
approved
Class
Route
ORAL
Patents
0
Programs
3
Data quality
0.84

Quick answer

primaquine phosphate (PRIMAQUINE PHOSPHATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN primaquine phosphate
Brand PRIMAQUINE PHOSPHATE
Mechanism Unknown
Route ORAL
Formulation TABLET

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ITDCVC98 Phase 3 · United Therapeutics Europe · Malaria
  2. Rituximab Phase 3 · United Therapeutics Europe · Follicular Lymphoma
  3. primaquine Approved · Repatha · Malaria, Vivax

Frequently asked questions

What is primaquine phosphate?

primaquine phosphate (PRIMAQUINE PHOSPHATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for primaquine phosphate?

PRIMAQUINE PHOSPHATE is a marketed brand name for primaquine phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of primaquine phosphate?

primaquine phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.